A Comparison of the Outcomes of Distal Fingertip Amputations Treated With Either Artificial (Xeroform) or Biological Dressings
Withdrawn
- Conditions
- Finger InjuriesAmputation, Traumatic
- Interventions
- Other: Skin GraftOther: Bacitracin
- Registration Number
- NCT03968835
- Lead Sponsor
- NYU Langone Health
- Brief Summary
This is a prospective study looking to evaluate whether the treatment outcomes for patients who sustain a distal fingertip amputation are improved or no different when using biological dressings versus artificial dressings.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- All individuals presenting at Bellevue Hospital for evaluation and treatment of a finger amputation distal to the germinal matrix that present along with the amputated distal fingertip unit.
Read More
Exclusion Criteria
- replantation candidate, incomplete distal finger-tip amputation
Read More
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Artificial Dressings Skin Graft the amputated composite skin and soft tissue unit will be thinned out to become a full thickness skin graft Biological Dressings Bacitracin Bacitracin will be applied and covered with xeroform and gauze
- Primary Outcome Measures
Name Time Method Time to complete healing up to 3 Months 3 months Percentage of graft viability (for biological dressing only) 3 months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
New York University School of Medicine
🇺🇸New York, New York, United States